Phase 2 Study of ADXS 11-001 Vaccination in HPV-positive Oropharyngeal Squamous Cell Carcinoma

Share this content:
Researchers are evaluating whether ADXS 11-001 vaccination prior to transoral surgery will improve outcomes for patients with HPV-positive oropharyngeal cancer.
Researchers are evaluating whether ADXS 11-001 vaccination prior to transoral surgery will improve outcomes for patients with HPV-positive oropharyngeal cancer.

Title: Window of Opportunity Trial of Neoadjuvant ADXS 11-001 Vaccination Prior to Robot-Assisted Resection of HPV-Positive Oropharyngeal Squamous Cell Carcinoma1

Study Chair: Andrew G Sikora, MD, PhD, Baylor College of Medicine

Description: For this phase 2, non-randomized trial, researchers are evaluating whether ADXS 11-001 vaccination prior to transoral surgery will improve outcomes for patients with HPV-positive oropharyngeal cancer.

The adverse events associated with standard treatments for HPV-positive disease can be severe, though survival rates are high. Vaccination, however, may cause tumor regression without chemotherapy or radiation, eliminating these side effects.

There are 2 arms for this study: in the first arm, patients will receive 2 ADXS 11-001 vaccination doses prior to surgery; in the second arm, patients will receive standard care.

The primary outcome is HPV E6/E7-specific CD8+ cytotoxic lymphocyte responses at different time points. Secondary outcomes include toxicity.

For more study information, including inclusion and exclusion criteria, study locations, and contact information, visit https://clinicaltrials.gov/ct2/show/NCT02002182.

Status: This study is open and enrolling patients as of April 11, 2017.

This study is sponsored by Andrew Sikora in collaboration with Advaxis, Inc.

Reference

  1. Clinicaltrials.gov. ADXS 11-001 vaccination prior to robotic surgery, HPV-positive oropharyngeal cancer. NCT02002182. https://clinicaltrials.gov/ct2/show/NCT02002182. Accessed April 11, 2017.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters